Cannabis Marketing: How to Advertise When Google and Meta Say No

Cannabis marketing strategy compliance and brand building in 2026

Author:

Ara Ohanian

Published:

October 24, 2025

Updated:

October 14, 2026

Submit an ad for a licensed dispensary to Meta, in a state where adult-use cannabis is legal, and expect it to be rejected. Meta’s policy takes one sentence: ads may not promote or offer the sale of THC products. Google’s is as short. Ads for substances taken to get high are not allowed. The state license doesn’t change that, and neither does the quality of the creative.

Crypto exchanges, online pharmacies, telehealth providers, addiction treatment centers, gambling operators and law firms all hear some version of the same no, from the two largest ad platforms or from the law underneath them. Each kind of no has a different fix, and cannabis shows all four.

There are four kinds of no, and each needs a different fix

The first is a prohibition. THC products on Google and Meta fall here. There is no certification, no appeal and no creative workaround that lasts, so the work goes into other channels.

The second is a no until you get permission. Google allows topical, hemp-derived CBD with 0.3% THC or less, but only in California, Colorado and Puerto Rico, and only after LegitScript certification. Meta allows CBD ads in the US with prior written permission and LegitScript certification, aimed at adults 18 and over, with no health claims. Crypto works the same way: Google requires certification and a local license in each country you target, and Meta requires written permission. So does gambling, which Google certifies country by country, and so do online pharmacies and addiction services, which need accreditation or certification. This kind of no costs paperwork and time.

The third is a yes with the lights off. Starting in January 2025, Meta began limiting what advertisers it classifies as health and wellness can do with their data. Depending on the level of restriction, custom URL parameters can’t be shared with Meta, and the advertiser can’t optimize for lower-funnel events such as add to cart and purchase. The ads run, but the system can’t optimize toward buyers, so the fix sits in measurement and campaign structure rather than creative.

The fourth is the law itself, which applies whatever a platform allows. California lets cannabis businesses advertise only where at least 71.6% of the audience is reasonably expected to be 21 or older. Massachusetts and Maryland set the bar at 85%, and Michigan allows no more than 30% of the audience to be under 21 for adult-use products. Here the fix is proof: being able to show, for every placement, why the audience met the threshold.

The common mistake is treating one kind of no as another: appealing a prohibition, rewriting creative for what is really a data restriction, or assuming that because a platform approved an ad, the state is satisfied.

Some platforms do take cannabis ads, on strict terms

X has allowed licensed US cannabis advertisers since February 2023. Its current policy requires pre-approval, limits targeting to the jurisdictions where the advertiser is licensed, bars targeting anyone under 21, bans offering cannabis for sale in the ad, and requires an age gate on the landing page. Snap says it allows some limited ads for cannabis where legal, with appropriate targeting. Spotify’s policy bans recreational drugs.

Google itself shows how policy follows national law. In Canada, where cannabis is federally legal, it runs a Search-only cannabis ads pilot that it extended through the end of 2026 and opened to more advertisers in April 2026. In the US, where adult-use cannabis is still federally illegal, nothing comparable exists.

Programmatic and connected TV sellers that accept cannabis have to meet the same state audience rules as you do. Before you buy, ask how the seller proves the 21-and-over share for each placement and whether that proof would satisfy your state regulator. If they can’t answer in writing, don’t buy.

Federal law moved in 2026, and the ad rules didn’t

In December 2025 an executive order told the Attorney General to complete the rescheduling process. A final rule effective 28 April 2026 moved FDA-approved marijuana products and state-licensed medical marijuana to Schedule III. Adult-use marijuana stayed in Schedule I, and in late September 2026 the judge overseeing the broader rescheduling hearing put the proceeding on hold.

No major ad platform has changed its THC policy since. The bigger change for advertisers is in hemp. A law signed in November 2025 redefines hemp by total THC, excludes cannabinoids synthesized outside the plant, and caps finished products at 0.4 milligrams of total THC per container. A September 2026 law then split the start date. Products containing cannabinoids the plant can’t produce naturally lose hemp status on 12 November 2026. The rest, including the exclusion for plant cannabinoids synthesized outside it and the 0.4 milligram cap, applies from 11 December 2026. Many intoxicating hemp products that can be sold and advertised today won’t meet the new definition.

Platform policies follow federal law slowly, and the federal timeline keeps moving, so plan around the policies in force today.

Crypto, health and legal services hit the same wall in different places

Crypto is the permission problem at its most complex. Google’s crypto policy changes country by country as licensing regimes like the EU’s MiCA come into force, and a firm cleared on one platform has every reason to keep spending there. That concentration carries its own risk, as one crypto firm found when most of its performance budget sat on X and its ads stopped delivering.

Health is the data problem. Telehealth providers and online pharmacies need LegitScript certification under Meta’s drug policy, and once they are running, Meta’s health and wellness rules limit what they can optimize for. In practice that means optimizing for the deepest event your account is still allowed to use, sending bookings and sales into your own CRM rather than trusting platform reporting, and judging campaigns on cost per booked appointment measured there. A holdout test, pausing ads in a few comparable regions for several weeks, tells you what the platform no longer can.

Legal services are the law problem. California’s SB 37, in force since January 2026, tightens content rules and, once the State Bar finds a violation, lets misled consumers sue for up to $100,000 per ad, as our guide to California attorney advertising rules explains. Consumer subscription businesses face the same kind of rule at the checkout, where the JustFab settlement shows what regulators look for. And any brand that reaches minors should see how Italian and Connecticut regulators have handled Gen Alpha beauty marketing.

Owned channels carry more of the load

Search comes first. People look for dispensaries, products, clinics and lawyers by name and by need, and organic results don’t require ad approval. Content that answers what buyers actually ask, product by product and question by question, earns traffic that doesn’t depend on an ad review. That is the core of content marketing for a restricted brand.

Email comes next, built on explicit consent and fast opt-outs. A list is an audience you can reach whatever the ad platforms decide, though inbox providers have rules of their own, covered in our guide to Gmail’s Manage subscriptions. SMS is harder for cannabis: US carriers block cannabis marketing texts even with consent, and Twilio states that cannabis messages aren’t allowed in the United States. Check your messaging provider’s policy before you build a text list.

Then the physical layer: packaging, in-store education, loyalty programs and events. For cannabis in particular, the budtender and the shelf answer questions an ad isn’t allowed to. Video fits across all of these. A short explainer that answers a real product question works on your site, in email, on the screens in your store and, where the platform allows it, as an ad.

Compliance review happens before media is booked

Keep a register of the policy for every platform you use, with the link and the date you last checked it, because these pages change and not every platform announces it. Track certification and permission renewals the way you track contract renewals. For every paid placement, keep the proof that it met your state’s audience rule. Archive every ad that runs, with dates and placements, and name one person who can pull any ad from every channel the same day.

Write the creative rules into every brief. The wording differs by category and state, but the substance repeats: nothing designed to appeal to people under the legal age, no health claims you can’t substantiate, the warnings and disclosures your state or platform requires, and landing pages that keep the promises the ad makes. Check whether your state’s rules cover your own social posts and website as well as paid media, and assume they do until you have confirmed otherwise.

Don’t let one platform carry the business. Even an approved channel can stop delivering for reasons that have nothing to do with policy. Build the second channel while the first is still delivering.

Aragil doesn’t take gambling, casino or betting clients. For brands in regulated categories, our performance marketing team plans media around these limits, and our privacy and compliance service audits the tracking and consent setup that Meta’s health restrictions depend on.

Frequently Asked Questions

Can cannabis companies advertise on Google?

Not for THC products. Google bans ads for substances taken to get high, including cannabis, in the US. Topical, hemp-derived CBD products with 0.3% THC or less can be advertised in California, Colorado and Puerto Rico after LegitScript certification. In Canada, Google is running a Search-only cannabis ads pilot through the end of 2026 for eligible advertisers. Organic search results don’t need ad approval, which is why SEO matters so much for cannabis brands.

Can you advertise CBD on Facebook and Instagram?

Yes, with conditions. Meta requires prior written permission and LegitScript certification for CBD ads, allows them only in the United States, and requires targeting at people 18 and over. Ads can’t make health claims. Hemp products with no CBD and no more than 0.3% THC have lighter rules. Ads that promote or sell THC products remain banned on Facebook and Instagram, whatever the state law where you operate.

Where can cannabis brands advertise online?

X accepts licensed US cannabis advertisers with pre-approval, targeting limited to the states where they are licensed, and an age gate on the landing page. Snap allows some limited cannabis ads where legal. Programmatic and connected TV sellers that accept cannabis must meet state audience rules, so ask for proof. Beyond paid media, search, consented email, your own site and in-store channels carry most of the load. US carriers block cannabis marketing texts, so SMS is rarely an option.

What is the 71.6% rule in cannabis advertising?

California law allows cannabis advertising only where at least 71.6% of the audience is reasonably expected to be 21 or older. It is set out in Business and Professions Code section 26151 and in state regulations. Other states use different thresholds: Massachusetts and Maryland require 85%, and Michigan allows no more than 30% of the audience to be under 21 for adult-use products. Keep audience data for every placement in case a regulator asks.

Did marijuana rescheduling change the advertising rules?

Not yet. A federal rule effective in April 2026 moved FDA-approved marijuana products and state-licensed medical marijuana to Schedule III, but adult-use marijuana remains in Schedule I, and the broader rescheduling proceeding was paused in September 2026. Google and Meta haven’t changed their THC policies. The more immediate change is for hemp, where a new federal definition starts applying in November and December 2026.